JP2010540649A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010540649A5 JP2010540649A5 JP2010528066A JP2010528066A JP2010540649A5 JP 2010540649 A5 JP2010540649 A5 JP 2010540649A5 JP 2010528066 A JP2010528066 A JP 2010528066A JP 2010528066 A JP2010528066 A JP 2010528066A JP 2010540649 A5 JP2010540649 A5 JP 2010540649A5
- Authority
- JP
- Japan
- Prior art keywords
- aliphatic
- pharmaceutically acceptable
- acceptable salt
- treating
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97730507P | 2007-10-03 | 2007-10-03 | |
| PCT/US2008/078239 WO2009045992A2 (en) | 2007-10-03 | 2008-09-30 | C-met protein kinase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010540649A JP2010540649A (ja) | 2010-12-24 |
| JP2010540649A5 true JP2010540649A5 (enExample) | 2012-10-18 |
Family
ID=40512401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010528066A Pending JP2010540649A (ja) | 2007-10-03 | 2008-09-30 | ｃ−ＭＥＴタンパク質の阻害剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8481524B2 (enExample) |
| EP (1) | EP2205589B1 (enExample) |
| JP (1) | JP2010540649A (enExample) |
| CN (1) | CN101990538A (enExample) |
| AT (1) | ATE502935T1 (enExample) |
| AU (1) | AU2008308900A1 (enExample) |
| CA (1) | CA2701124A1 (enExample) |
| DE (1) | DE602008005786D1 (enExample) |
| ES (1) | ES2361650T3 (enExample) |
| MX (1) | MX2010003563A (enExample) |
| NZ (1) | NZ584311A (enExample) |
| WO (1) | WO2009045992A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2011004188A (es) | 2008-10-21 | 2011-06-09 | Vertex Pharma | Inhibidores de la proteina cinasa c-met. |
| KR20120112755A (ko) | 2010-01-07 | 2012-10-11 | 이 아이 듀폰 디 네모아 앤드 캄파니 | 살진균제 복소환 화합물 |
| EP2588107A1 (en) | 2010-07-01 | 2013-05-08 | Takeda Pharmaceutical Company Limited | COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET |
| EP2940002B1 (en) | 2012-12-25 | 2016-12-14 | Nippon Soda Co., Ltd. | Halogenated aniline and method for producing same |
| CN103242216A (zh) * | 2013-05-07 | 2013-08-14 | 兰州梦唐精细化工有限公司 | N- Boc -六氢-5-氧代环戊[C]并吡咯的合成方法 |
| US9896436B2 (en) | 2014-09-16 | 2018-02-20 | Celgene Quanticel Research, Inc. | Histone demethylase inhibitors |
| EA201790502A1 (ru) | 2014-09-16 | 2017-10-31 | Селджен Квонтисел Рисёрч, Инк. | Ингибиторы гистоновых диметилаз |
| ES2764299T3 (es) | 2014-12-09 | 2020-06-02 | Inst Nat Sante Rech Med | Anticuerpos monoclonales humanos contra AXL |
| WO2016135041A1 (en) | 2015-02-26 | 2016-09-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Fusion proteins and antibodies comprising thereof for promoting apoptosis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1697352B1 (en) * | 2003-09-24 | 2012-06-27 | Vertex Pharmceuticals Incorporated | 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase |
| US7169781B2 (en) * | 2003-10-17 | 2007-01-30 | Hoffmann-La Roche Inc. | Imidazole derivatives and their use as pharmaceutical agents |
| RU2008141761A (ru) * | 2006-03-22 | 2010-04-27 | Вертекс Фармасьютикалз Инкорпорейтед (Us) | ИНГИБИТОРЫ с-МЕТ ПРОТЕИНКИНАЗЫ |
-
2008
- 2008-09-30 DE DE602008005786T patent/DE602008005786D1/de active Active
- 2008-09-30 ES ES08835773T patent/ES2361650T3/es active Active
- 2008-09-30 MX MX2010003563A patent/MX2010003563A/es active IP Right Grant
- 2008-09-30 CA CA2701124A patent/CA2701124A1/en not_active Abandoned
- 2008-09-30 CN CN2008801170093A patent/CN101990538A/zh active Pending
- 2008-09-30 EP EP08835773A patent/EP2205589B1/en not_active Not-in-force
- 2008-09-30 WO PCT/US2008/078239 patent/WO2009045992A2/en not_active Ceased
- 2008-09-30 NZ NZ584311A patent/NZ584311A/en not_active IP Right Cessation
- 2008-09-30 AU AU2008308900A patent/AU2008308900A1/en not_active Abandoned
- 2008-09-30 JP JP2010528066A patent/JP2010540649A/ja active Pending
- 2008-09-30 AT AT08835773T patent/ATE502935T1/de not_active IP Right Cessation
-
2010
- 2010-03-31 US US12/751,016 patent/US8481524B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010540649A5 (enExample) | ||
| US11267782B2 (en) | Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2α inhibitors | |
| US12077506B2 (en) | Indane derivatives as hypoxia inducible factor-2(α) inhibitors | |
| JP6342805B2 (ja) | 置換ピラゾロ［３，４−ｄ］ピリミジンおよびその用途 | |
| JP5461189B2 (ja) | キナーゼ活性の阻害剤 | |
| JP2012506381A5 (enExample) | ||
| KR20170049604A (ko) | Bub1 억제제로서의 벤질 치환된 인다졸 | |
| JP2016526540A5 (enExample) | ||
| JP2018531921A (ja) | Ｂ型肝炎ウイルスコアタンパク質モジュレーター | |
| US12171741B2 (en) | 2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors | |
| JP2014521688A5 (enExample) | ||
| EP2960234A1 (en) | Trk-INHIBITING COMPOUND | |
| JP2015536997A5 (enExample) | ||
| EA201070783A1 (ru) | 1,2,4-оксадизольные соединения для лечения аутоиммунных заболеваний | |
| JP2017524003A5 (enExample) | ||
| JP2015519347A5 (enExample) | ||
| JP2016508145A5 (enExample) | ||
| JP2017523141A5 (enExample) | ||
| WO2019043706A1 (en) | NOVEL BARBITURIC ACID DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS INHIBITORS OF LEUKOCYTE TRANSMIGRATION, THE TREATMENT OF INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES AND CANCER | |
| TW201406759A (zh) | Ｖｅｇｆｒ－３抑制劑於治療肝細胞癌之用途 | |
| US12479870B2 (en) | Base-modified cytidine nucleotides for leukemia therapy | |
| JP2016505049A5 (enExample) | ||
| CN1678310A (zh) | 用于治疗良性和恶性肿瘤疾病的含有disorazole及其衍生物的药物 | |
| WO2019245444A1 (en) | Base-modified cytidine nucleotides for leukemia therapy | |
| HK1236531A1 (en) | Benzimidazol-2-amines as midh1 inhibitors |